Welcome Guest | Register / Login

North America Blood Plasma Market Forecast 2019-2027

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study and Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top-Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Provision of Better Healthcare Infrastructure In Developed Countries
3.2.2. Immunoglobulin Blood Type Holds The Largest Market Share
3.2.3. Transplantation Is Anticipated To Be The Fastest-Growing Therapeutic Indication In Blood Plasma
4. Market Determinants
4.1. Market Drivers
4.1.1. Widespread Acceptance of Immunoglobulin-Based Therapies
4.1.2. Growing Usages of Albumin In Other Therapeutic Areas
4.1.3. Growing Geriatric Population
4.1.4. Rising Prevalence of Alpha-1 Antitrypsin Deficiency (Aatd)
4.1.5. Increase In The Patient Pool For Hemophilia Treatment
4.2. Restraints
4.2.1. Increasing Usage of Recombinant Plasma Products In Therapeutic Treatments
4.2.2. High Costs of Blood Plasma Treatments
4.2.3. Adverse Reactions Associated With Post-Transfusion
4.3. Opportunities
4.3.1. Rising Incidence of Hemophilia
4.3.2. Growing Public Awareness
4.3.3. New Product Opportunities
4.4. Challenges
4.4.1. Spread of Pathogenic Contaminants
4.4.2. High Regulations In The Market
5. Market By Mode of Delivery
5.1. Infusion Solutions
5.2. Gels
5.3. Sprays
5.4. Biomedical Sealants
6. Market By Blood Type
6.1. Immunoglobulin
6.1.1. Intravenous Immunoglobulin
6.1.2. Subcutaneous Immunoglobulin
6.1.3. Other Immunoglobulin Type
6.2. Albumin
6.3. Hyperimmunes
6.4. Coagulation Factor Concentrates
6.5. Other Plasma Fractionation Products
7. Market By Therapeutic Indication
7.1. Immunology
7.2. Oncology
7.3. Pulmonology
7.4. Rheumatology
7.5. Transplantation
7.6. Neurology
7.7. Hematology
7.8. Other Application
8. Market By Application
8.1. Hemophilia
8.2. Hypogammaglobulinemia
8.3. Immunodeficiency Diseases
8.4. Von Willebrand Disease (Vwd)
8.5. Other Application
9. Market By End User
9.1. Hospitals and Clinics
9.2. Research Laboratories
9.3. Academic Institutions
10. Key Analytics
10.1. Porter's Five Forces Model
10.1.1. Threat of New Entrants
10.1.2. Threat of Substitute
10.1.3. Bargaining Power of Buyers
10.1.4. Bargaining Power of Suppliers
10.1.5. Threat of Competitive Rivalry
10.2. Plasma Therapeutics Regulation
10.3. Market Trends
10.4. Regulatory Agencies
10.5. Clinical Guidelines
10.6. Opportunity Matrix
11. Geographical Analysis
11.1. North America
11.1.1. The United States
11.1.2. Canada
12. Company Profiles
12.1. Adma Biologics Inc.
12.2. Arthrex
12.3. Baxter International Inc.
12.4. Biotest Ag
12.5. Cerus Corp.
12.6. China Biologic Products Inc.
12.7. Csl Ltd.
12.8. Grifols International S.A.
12.9. Octopharma Ag
12.10. Shire Plc (Aquired By Takeda)
12.11. Kedrion Biopharma Inc.

List of Tables

Table 1: North America Blood Plasma Market 2019-2027 ($ Million)
Table 2: Blood Plasma Components
Table 3: North America Blood Plasma Market, By Blood Type, 2019-2027 ($ Million)
Table 4: North America Immunoglobulin Market, 2019-2027 ($ Million)
Table 5: North America Blood Plasma Market, By Immunoglobulin Type, 2019-2027 ($ Million)
Table 6: North America Intravenous Immunoglobulin Market, 2019-2027 ($ Million)
Table 7: North America Subcutaneous Immunoglobulin Market, 2019-2027 ($ Million)
Table 8: North America Other Immunoglobulin Type Market, 2019-2027 ($ Million)
Table 9: North America Albumin Market, 2019-2027 ($ Million)
Table 10: North America Hyperimmunes Market, 2019-2027 ($ Million)
Table 11: North America Coagulation Factor Concentrates Market, 2019-2027 ($ Million)
Table 12: North America Other Plasma Fractionation Products, 2019-2027 ($ Million)
Table 13: Protease Inhibitors Used In The Hiv Infection Treatment
Table 14: North America Blood Plasma Market, By Therapeutic Indication, 2019-2027 ($ Million)
Table 15: North America Immunology Market, 2019-2027 ($ Million)
Table 16: North America Oncology Market, 2019-2027 ($ Million)
Table 17: North America Pulmonology Market, 2019-2027 ($ Million)
Table 18: North America Rheumatology Market, 2019-2027 ($ Million)
Table 19: North America Transplantation Market, 2019-2027 ($ Million)
Table 20: North America Neurology Market, 2019-2027 ($ Million)
Table 21: North America Hematology Market, 2019-2027 ($ Million)
Table 22: North America Other Application Market, 2019-2027 ($ Million)
Table 23: North America Blood Plasma Market, By Application, 2019-2027 ($ Million)
Table 24: North America Hemophilia Market, 2019-2027 ($ Million)
Table 25: North America Hypogammaglobulinemia Market, 2019-2027 ($ Million)
Table 26: North America Immunodeficiency Diseases Market, 2019-2027 ($ Million)
Table 27: North America Von Willebrand Disease (Vwd) Market, 2019-2027 ($ Million)
Table 28: North America Other Application Market, 2019-2027 ($ Million)
Table 29: North America Blood Plasma Market, By End User, 2019-2027 ($ Million)
Table 30: North America Hospitals and Clinics Market, 2019-2027 ($ Million)
Table 31: North America Research Laboratories Market, 2019-2027 ($ Million)
Table 32: North America Academic Institutions Market, 2019-2027 ($ Million)
Table 33: North America Blood Plasma Market, By Country, 2019-2027 ($ Million)

List of Figures

Figure 1: North America Blood Plasma Market 2019-2027 ($ Million)
Figure 2: Immunoglobulin Infusions Side Effects
Figure 3: Role of Fibrin Sealant In Coagulation Cascade
Figure 4: North America Blood Plasma Market, By Immunoglobulin, 2019-2027 ($ Million)
Figure 5: North America Blood Plasma Market, By Albumin, 2019-2027 ($ Million)
Figure 6: Hyperimmunes Isolation Process
Figure 7: North America Blood Plasma Market, By Hyperimmunes, 2019-2027 ($ Million)
Figure 8: North America Blood Plasma Market, By Coagulation Factor Concentrates, 2019-2027 ($ Million)
Figure 9: North America Blood Plasma Market, By Other Plasma Fractionation Products, 2019-2027 ($ Million)
Figure 10: North America Blood Plasma Market, By Immunology, 2019-2027 ($ Million)
Figure 11: North America Blood Plasma Market, By Oncology, 2019-2027 ($ Million)
Figure 12: North America Blood Plasma Market, By Pulmonology, 2019-2027 ($ Million)
Figure 13: Lupus Infection Symptoms
Figure 14: North America Blood Plasma Market, By Rheumatology, 2019-2027 ($ Million)
Figure 15: North America Blood Plasma Market, By Transplantation, 2019-2027 ($ Million)
Figure 16: North America Blood Plasma Market, By Neurology, 2019-2027 ($ Million)
Figure 17: North America Blood Plasma Market, By Hematology, 2019-2027 ($ Million)
Figure 18: North America Blood Plasma Market, By Other Applications, 2019-2027 ($ Million)
Figure 19: North America Blood Plasma Market, By Hemophilia, 2019-2027 ($ Million)
Figure 20: North America Blood Plasma Market, By Hypogammaglobulinemia, 2019-2027 ($ Million)
Figure 21: North America Blood Plasma Market, By Immunodeficiency Diseases, 2019-2027 ($ Million)
Figure 22: North America Blood Plasma Market, By Von Willebrand Disease (Vwd), 2019-2027 ($ Million)
Figure 23: North America Blood Plasma Market, By Other Application, 2019-2027 ($ Million)
Figure 24: North America Blood Plasma Market, By Hospitals and Clinics, 2019-2027 ($ Million)
Figure 25: North America Blood Plasma Market, By Research Laboratories, 2019-2027 ($ Million)
Figure 26: North America Blood Plasma Market, By Academic Institutions, 2019-2027 ($ Million)
Figure 27: Porter's Five Force Model
Figure 28: The United States Blood Plasma Market, 2019-2027 ($ Million)
Figure 29: Canada Blood Plasma Market, 2019-2027 ($ Million)
Single User License: This License type does not allow the report to be Printed.
Five User License: This License type does not allow the report to be Printed.
Enterprise License: This License type does not allow the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :Inkwood Research
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy